Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 53

1.

Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants in Pregnancy and Congenital Anomalies: Analysis of Linked Databases in Wales, Norway and Funen, Denmark.

Jordan S, Morris JK, Davies GI, Tucker D, Thayer DS, Luteijn JM, Morgan M, Garne E, Hansen AV, Klungsøyr K, Engeland A, Boyle B, Dolk H.

PLoS One. 2016 Dec 1;11(12):e0165122. doi: 10.1371/journal.pone.0165122.

2.

Selective serotonin reuptake inhibitors and pregnancy: A review of maternal, fetal and neonatal risks and benefits.

Marchocki Z, Russell NE, Donoghue KO.

Obstet Med. 2013 Dec;6(4):155-8. doi: 10.1177/1753495X13495194. Review.

3.

The Risk of Congenital Heart Anomalies Following Prenatal Exposure to Serotonin Reuptake Inhibitors-Is Pharmacogenetics the Key?

Daud AN, Bergman JE, Kerstjens-Frederikse WS, Groen H, Wilffert B.

Int J Mol Sci. 2016 Aug 13;17(8). pii: E1333. doi: 10.3390/ijms17081333. Review.

4.

Effects of Fluoxetine on Human Embryo Development.

Kaihola H, Yaldir FG, Hreinsson J, Hörnaeus K, Bergquist J, Olivier JD, Åkerud H, Sundström-Poromaa I.

Front Cell Neurosci. 2016 Jun 16;10:160. doi: 10.3389/fncel.2016.00160.

5.

Selective serotonin reuptake inhibitor exposure constricts the mouse ductus arteriosus in utero.

Hooper CW, Delaney C, Streeter T, Yarboro MT, Poole S, Brown N, Slaughter JC, Cotton RB, Reese J, Shelton EL.

Am J Physiol Heart Circ Physiol. 2016 Sep 1;311(3):H572-81. doi: 10.1152/ajpheart.00822.2015.

PMID:
27371685
6.

Maternal exposure to carbamazepine at environmental concentrations can cross intestinal and placental barriers.

Kaushik G, Huber DP, Aho K, Finney B, Bearden S, Zarbalis KS, Thomas MA.

Biochem Biophys Res Commun. 2016 May 27;474(2):291-5. doi: 10.1016/j.bbrc.2016.04.088.

7.

The risk of major cardiac malformations associated with paroxetine use during the first trimester of pregnancy: a systematic review and meta-analysis.

Bérard A, Iessa N, Chaabane S, Muanda FT, Boukhris T, Zhao JP.

Br J Clin Pharmacol. 2016 Apr;81(4):589-604. doi: 10.1111/bcp.12849. Review.

PMID:
26613360
8.

Antidepressants, anxiolytics, and hypnotics in pregnancy and lactation.

Ram D, Gandotra S.

Indian J Psychiatry. 2015 Jul;57(Suppl 2):S354-71. doi: 10.4103/0019-5545.161504. Review.

9.

Behavioural effects of fetal antidepressant exposure in a Norwegian cohort of discordant siblings.

Brandlistuen RE, Ystrom E, Eberhard-Gran M, Nulman I, Koren G, Nordeng H.

Int J Epidemiol. 2015 Aug;44(4):1397-407. doi: 10.1093/ije/dyv030.

10.

Placental transfer of antidepressant medications: implications for postnatal adaptation syndrome.

Ewing G, Tatarchuk Y, Appleby D, Schwartz N, Kim D.

Clin Pharmacokinet. 2015 Apr;54(4):359-70. doi: 10.1007/s40262-014-0233-3. Review.

11.

Pharmacokinetics of fluoxetine in pregnant baboons (Papio spp.).

Shoulson RL, Stark RL, Garland M.

J Am Assoc Lab Anim Sci. 2014 Nov;53(6):708-16.

12.

The effect of antenatal depression and selective serotonin reuptake inhibitor treatment on nerve growth factor signaling in human placenta.

Kaihola H, Olivier J, Poromaa IS, Åkerud H.

PLoS One. 2015 Jan 22;10(1):e0116459. doi: 10.1371/journal.pone.0116459.

13.

Early-life exposure to the SSRI paroxetine exacerbates depression-like behavior in anxiety/depression-prone rats.

Glover ME, Pugh PC, Jackson NL, Cohen JL, Fant AD, Akil H, Clinton SM.

Neuroscience. 2015 Jan 22;284:775-97. doi: 10.1016/j.neuroscience.2014.10.044.

14.

Monoamine-sensitive developmental periods impacting adult emotional and cognitive behaviors.

Suri D, Teixeira CM, Cagliostro MK, Mahadevia D, Ansorge MS.

Neuropsychopharmacology. 2015 Jan;40(1):88-112. doi: 10.1038/npp.2014.231. Review.

15.

Genome-wide DNA methylation in neonates exposed to maternal depression, anxiety, or SSRI medication during pregnancy.

Non AL, Binder AM, Kubzansky LD, Michels KB.

Epigenetics. 2014 Jul;9(7):964-72. doi: 10.4161/epi.28853.

16.

Prenatal SSRI use and offspring with autism spectrum disorder or developmental delay.

Harrington RA, Lee LC, Crum RM, Zimmerman AW, Hertz-Picciotto I.

Pediatrics. 2014 May;133(5):e1241-8. doi: 10.1542/peds.2013-3406.

17.

Prenatal antidepressant exposure: clinical and preclinical findings.

Bourke CH, Stowe ZN, Owens MJ.

Pharmacol Rev. 2014 Feb 24;66(2):435-65. doi: 10.1124/pr.111.005207. Review.

18.

Pharmacotherapy for mood disorders in pregnancy: a review of pharmacokinetic changes and clinical recommendations for therapeutic drug monitoring.

Deligiannidis KM, Byatt N, Freeman MP.

J Clin Psychopharmacol. 2014 Apr;34(2):244-55. doi: 10.1097/JCP.0000000000000087. Review.

19.

Antidepressant use in pregnant and postpartum women.

Yonkers KA, Blackwell KA, Glover J, Forray A.

Annu Rev Clin Psychol. 2014;10:369-92. doi: 10.1146/annurev-clinpsy-032813-153626. Review.

20.
Items per page

Supplemental Content

Support Center